Sun Pharma falls on worries US cancer drug supply contact may end

Sun Pharmaceutical Industries fell on worries, the company will soon see an end to its temporary arrangement to supply a cancer drug in the United States.

The company had been supplying an alternative version of Doxil called Lipodox in the United States under a temporary arrangement with the Food and Drug Administration.Shares of the companyare trading at Rs 691.90, down Rs 7.8, or 1.11% at the Bombay Stock Exchange (BSE) on Friday at 12:00 p.m.The scrip has touched an intra-day high of Rs 699.10 and low of Rs 689.05. The total volume of shares traded at the BSE is 17,721.In the earlier session, the shares lost 1.73%, or Rs 12.35, at Rs 699.70. Currently, the stock is trading down 5.08% from its 52-week high of Rs 728.95 and above 48.51% over the 52-week low of Rs 465.90.

Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 714.80 (15.10) (2.11) 1 Month 672.30 27.40 4.08 3 Months 625.05 74.65 11.94 6 Months 588.85 110.85 18.82 1 Year 488.05 211.65 43.37 Note: Based on previous day closing price.